| IV-32 Claudio Monteiro Sousa An in silico HBV model predicts viral response to the oral non-steroidal carboxylic acid FXR agonist EYP001a. Thursday 15:10-16:40 |
| IV-32 Claudio Monteiro Sousa An in silico HBV model predicts viral response to the oral non-steroidal carboxylic acid FXR agonist EYP001a. Thursday 15:10-16:40 |